Home › Heart Attack › Alabama › Huntsville
Heart Attack clinical trials in Huntsville, AL
3 studies for Heart Attack are looking for participants at sites in and around Huntsville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Nephrology Consultants, LLC, Huntsville
- Nephrology of North Alabama, Decatur · 24 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Heart Center Research Llc, Huntsville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Heart Center Research LLC, Huntsville
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- New York City, NY7 studies
- Dallas, TX6 studies
- Boston, MA6 studies
- Rochester, MN6 studies
- Hartford, CT4 studies
- Nashville, TN4 studies
- Houston, TX4 studies
- Boca Raton, FL4 studies
- Los Angeles, CA4 studies
- Knoxville, TN4 studies
- Detroit, MI4 studies
- Greensboro, NC4 studies
Other studies in Huntsville
- Cardiovascular Disease8 studies
- Obesity7 studies
- Coronary Artery Disease6 studies
- Heart Failure6 studies
- Major Depressive Disorder6 studies
- Type 2 Diabetes6 studies
- Depression6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Aortic Valve Stenosis4 studies
- Chronic Kidney Disease4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.